Biohaven jumps as cancer treatment shows promise in early-stage trial
U.S. RESEARCH ROUNDUP- Agios Pharmaceuticals, Dycom Industries, Lowe's Companies
U.S. STOCKS ON THE MOVE-TransDigm, Citigroup, Cisco Systems
U.S. STOCKS ON THE MOVE-Floor & Decor, Starbucks, gold miners
U.S. STOCKS ON THE MOVE-ExxonMobil, Yatra, Venture Global
Biohaven slumps on pricing $175 mln stock deal
Biohaven slumps after $150 mln stock sale plans announced
Brief: Biohaven Announces Proposed Public Offering Of Common Shares
Biopharma firm Biohaven's Q3 net loss widens to $173.4 mln
U.S. RESEARCH ROUNDUP-Acadia Pharmaceuticals, Applovin Corp, Centuri Holdings
U.S. STOCKS ON THE MOVE-Targa Resources, Illumina, Alphabet
U.S. STOCKS ON THE MOVE-Bunge, O'Reilly Automotive, Targa Resources
Biohaven shares plunge after US FDA declines to approve brain disorder drug
U.S. STOCKS ON THE MOVE-Lemonade, New York Times, Johnson Controls
U.S. STOCKS ON THE MOVE-McDonald's, Lumentum, Humana
Biohaven falls as US FDA rejects rare nerve disease drug application
U.S. RESEARCH ROUNDUP- Equifax, Johnson & Johnson, Morgan Stanley
Biohaven climbs as FDA says no advisory committee needed for genetic disorder drug
Brief: Biohaven Files Prospectus Related To Register Resale Of Up To 3.6 Million Common Shares